Biotech Target N V - Jul 17, 2023 Form 4 Insider Report for Molecular Templates, Inc. (MTEM)

Role: 10%+ Owner
Signature: /s/Ivo Betschart
Stock symbol: MTEM
Transactions as of: Jul 17, 2023
Transactions value $: $2,000,000
Form type: 4
Date filed: 7/19/2023, 03:14 PM
Previous filing: Feb 16, 2023
Next filing: Sep 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MTEM	Common Stock	Purchase	$2M	+4.26M	+38.02%	$0.47^*	15.4M	Jul 17, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.